MAP3K13 antibody (Center)

Catalog No. ABIN5620099

Product Details anti-MAP3K13 Antibody

Target: MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))

Binding Specificity: Center

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This MAP3K13 antibody is un-conjugated

Application: Western Blotting (WB), Immunoprecipitation (IP)

Specificity: Recognizes endogenous levels of LZK protein

Cross-Reactivity (Details): Mouse, Rat, Bovine, Chicken, Dog, Rabbit

Characteristics: Purified Polyclonal LZK antibody

Purification: LZK antibody was purified by immunogen affinity chromatography

Immunogen: LZK antibody was raised in Rabbit using a KLH-conjugated synthetic peptide encompassing a sequence within the center region of human LZK as the immunogen

Application Details

Application Notes: WB: 1:500 - 1:1000, IP: 1:10 - 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Supplied in liquid form in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3 with 30 % glycerol and 0.01 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 deg C for short term storage. For long term, aliquot and store at -20 deg C. Avoid repeat freeze/thaw cycles

Target Details for MAP3K13

Target: MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))

Alternative Name: LZK (MAP3K13 Products)

Synonyms: LZK antibody, MEKK13 antibody, MLK antibody, C130026N12Rik antibody, lzk antibody, map3k13 antibody, map3k13a antibody, mekk13 antibody, map3k13-a antibody, map3k13-b antibody, map3k13b antibody, mitogen-activated protein kinase kinase kinase 13 antibody, mitogen-activated protein kinase kinase kinase 13 L homeolog antibody, mitogen-activated protein kinase kinase kinase 13 S homeolog antibody, MAP3K13 antibody, Map3k13 antibody, map3k13.L antibody, map3k13 antibody, map3k13.S antibody

Pathways: Signaling Events mediated by VEGFR1 and VEGFR2